
-
Aura Biosciences Inc NASDAQ:AURA
Location: | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services
Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
215.3M
Cash
174.4M
Avg Qtr Burn
-18.31M
Short % of Float
3.54%
Insider Ownership
3.10%
Institutional Own.
82.85%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Belzupacap Sarotalocan (Bel-sar) Details Primary Choroidal Melanoma | Phase 3 Data readout | |
Belzupacap Sarotalocan (Bel-sar) (Suprachoroidal (SC) Administration) Details Primary Choroidal Melanoma | Phase 2 Update | |
Belzupacap Sarotalocan (Bel-sar) (AU-011) Details Non-muscle invasive bladder cancer, Muscle-invasive bladder cancer | Phase 1 Data readout |